Skip to main content
. 2020 Jun 28;21(9):799–805. doi: 10.1080/15384047.2020.1779005

Figure 2.

Figure 2.

GUCY2C ligand mRNA expression is retained after monoallelic loss of APC. (a) GUCY2C, uroguanylin, and guanylin mRNA expression quantified by RNAseq in colorectal carcinomas, classified by stage of disease [stage I (n = 57), stage II (n = 136), stage III (n = 113), stage IV (n = 52)], and normal colorectum (n = 51) from the TCGA database.38 (b) GUCY2C and uroguanylin mRNA quantified by qRT-PCR from jejunum in wildtype (n = 12), Apcmin/+ (n = 11), Guca2b−/- (n = 3) and ApcCKO (n = 5) mice. (c) GUCY2C and guanylin mRNA quantified by qRT-PCR from proximal colon in wildtype (n = 12), Apcmin/+ (n = 11), Guca2a−/- (n = 3) and ApcCKO (n = 5) mice. n.s., not significant, * p < .05, ** p < .01, *** p < .001, **** p < .0001.